V025-2653 Screening compound: N-BENZYL-N'-(8-CHLORO-11-MORPHOLINODIBENZO[B,F][1,4]OXAZEPIN-2-YL)UREA

V025-2653 Screening compound: N-BENZYL-N'-(8-CHLORO-11-MORPHOLINODIBENZO[B,F][1,4]OXAZEPIN-2-YL)UREA
V025-2653 Screening compound: N-BENZYL-N'-(8-CHLORO-11-MORPHOLINODIBENZO[B,F][1,4]OXAZEPIN-2-YL)UREA alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-2653
N-BENZYL-N'-(8-CHLORO-11-MORPHOLINODIBENZO[B,F][1,4]OXAZEPIN-2-YL)UREA

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-2653

Molecular Formula

C25H23ClN4O3 (C25 H23 ClN4 O3)

Compound Name

N-BENZYL-N'-(8-CHLORO-11-MORPHOLINODIBENZO[B,F][1,4]OXAZEPIN-2-YL)UREA

IUPAC name

n/a

SMILES

O=C(NCc1ccccc1)Nc(cc1)cc2c1Oc(ccc(Cl)c1)c1N=C2N1CCOCC1

InChI

InChI=1S/C25H23ClN4O3/c26-18-6-8-23-21(14-18)29-24(30-10-12-32-13-11-30)20-15-19(7-9-22(20)33-23)28-25(31)27-16-17-4-2-1-3-5-17/h1-9,14-15H,10-13,16H2,(H2,27,28,31)

InChI Key

PCWBZPGSNLDNKG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14265871

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.94

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.247

Distribution Coefficient, logD

4.180

Water Solubility, LogSw

-4.65

Polar Surface Area

59.796

Acid Dissociation Constant (pKa)

13.98

Base Dissociation Constant (pKb)

6.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

V025-2653 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V025-2653 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-2653?
Check Price and Availability of V025-2653, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-2653 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-2653
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-2653
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-2653 available by request